Amgen

Amgen severs 14-year Cytokinetics partnership, bailing on omecamtiv after mixed PhIII results
Amgen severs 14-year Cytokinetics partnership, bailing on omecamtiv after mixed PhIII results
Endpoints
Amgen
Cytokinetics
omecamtiv
clinical trials
Flag link:
AHA 2020 – look out for the omecamtiv fault lines
AHA 2020 – look out for the omecamtiv fault lines
EP Vantage
AHA
Omecamtiv Mecarbil
Amgen
Cytokinetics
heart failure
Flag link:
Amgen, AstraZeneca's tezepelumab hits goal in asthma phase 3
Amgen, AstraZeneca's tezepelumab hits goal in asthma phase 3
Fierce Pharma
Amgen
AstraZeneca
tezepelumab
asthma
severe asthma
clinical trials
Flag link:
Bristol Myers' psoriasis drug beats Amgen rival in phase 3
Bristol Myers' psoriasis drug beats Amgen rival in phase 3
Fierce Biotech
Bristol-Myers Squibb
deucravacitinib
Amgen
Otezla
clinial trials
plaque psoriasis
Flag link:
Thank Otezla for Amgen's Q3 Revenue and Earnings Beats
Thank Otezla for Amgen's Q3 Revenue and Earnings Beats
Motley Fool
Amgen
earnings
Otezla
Flag link:
Amgen Reports Stronger-Than-Expected Q3 Earnings; Revenue Gains 12%
Amgen Reports Stronger-Than-Expected Q3 Earnings; Revenue Gains 12%
TheStreet.com
Amgen
Flag link:
Closely Watched Mirati Reveals Results to Rival Amgen Drug
Closely Watched Mirati Reveals Results to Rival Amgen Drug
Bloomberg
Mirati Therapeutics
Amgen
adagrasib
lung cancer
Flag link:
Amgen and Cytokinetics claim heart drug success, but results widely disappoint
Amgen and Cytokinetics claim heart drug success, but results widely disappoint
BioPharma Dive
Amgen
Cytokinetics
Servier
clinical trials
Omecamtiv Mecarbil
cardiovascular disease
Flag link:
Amgen teases 'promising' phase 2 data for closely watched KRAS prospect
Amgen teases 'promising' phase 2 data for closely watched KRAS prospect
Fierce Biotech
Amgen
clinical trials
non-small cell lung cancer
KRAS
sotorasib
Flag link:
Amgen Highlights Long-Term Aimovig Data for Episodic Migraine
Amgen Highlights Long-Term Aimovig Data for Episodic Migraine
BioSpace
Amgen
Novartis
Aimovig
migraines
episodic migraines
Flag link:
Novartis, Amgen and Mallinckrodt used aggressive price hikes to meet sales goals, congressional probe finds
Novartis, Amgen and Mallinckrodt used aggressive price hikes to meet sales goals, congressional probe finds
Fierce Pharma
congress
drug pricing
Novartis
Amgen
Mallinckrodt
Flag link:
Bristol, Amgen, Teva CEOs among execs to testify at House drug pricing hearings next week
Bristol, Amgen, Teva CEOs among execs to testify at House drug pricing hearings next week
Fierce Pharma
drug pricing
regulatory
Celgene
Bristol-Myers Squibb
Teva Pharmaceutical
Amgen
Novartis
Mallinckrodt
AbbVie
US Congress
Flag link:
Amgen publishes, presents data on therapy with ‘undruggable’ target
Amgen publishes, presents data on therapy with ‘undruggable’ target
MedCity News
Amgen
sotorasib
ESMO
AMG 510
non-small cell lung cancer
Flag link:
Eli Lilly, Amgen join forces to scale production of COVID-19 antibody cocktails
Eli Lilly, Amgen join forces to scale production of COVID-19 antibody cocktails
Fierce Pharma
Eli Lilly
Amgen
LY-CoV-55
antibody cocktail
COVID-19
Flag link:
ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
Fierce Pharma
ESC
Amgen
Repatha
Sanofi
Regeneron
Praluent
cholesterol
Flag link:
A new biotech forms to revive Amgen's old heart drug
A new biotech forms to revive Amgen's old heart drug
BioPharma Dive
Amgen
NewAmsterdam Pharma
obicetrapib
heart disease
Flag link:
AbbVie's Skyrizi stands to gain as docs move away from older psoriasis meds—Amgen's Otezla included
AbbVie's Skyrizi stands to gain as docs move away from older psoriasis meds—Amgen's Otezla included
Fierce Pharma
psoriasis
AbbVie
Skyrizi
Amgen
Celgene
Otezla
Flag link:
Amgen-partnered researchers treat diabetes in mice by silencing IL-2's inflammatory power
Amgen-partnered researchers treat diabetes in mice by silencing IL-2's inflammatory power
Fierce Biotech
Amgen
Flag link:
Teva's Ajovy, chasing Amgen and Lilly drugs, gains steam after autoinjector rollout
Teva's Ajovy, chasing Amgen and Lilly drugs, gains steam after autoinjector rollout
Fierce Pharma
Teva Pharmaceutical
migraines
Ajovy
autoinjectors
Amgen
Eli Lilly
Flag link:
Platform study designed to rapidly screen potential Covid-19 drugs enrolls first patients
Platform study designed to rapidly screen potential Covid-19 drugs enrolls first patients
MedCity News
COVID-19
Amgen
AbbVie
Takeda
patients
clinical trials
Flag link:

Pages